Close

Janssen Biotech (JNJ) Enters License Agreement with TESARO (TSRO) for Niraparib

April 6, 2016 7:05 AM EDT Send to a Friend
Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ), announced today it has entered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login